Tenax Therapeutics CEO Christopher Giordano's 2023 pay slips 3% to $645K
Tenax Therapeutics reports 2023 executive compensation
By ExecPay News
Published: September 27, 2024
Tenax Therapeutics reported fiscal year 2023 executive compensation information on September 27, 2024.
In 2023, three executives at Tenax Therapeutics received on average a compensation package of $431K, a 5% decrease compared to previous year.
Average pay of disclosed executives at Tenax Therapeutics
Christopher T. Giordano, Chief Executive Officer, received $645K in total, which decreased by 3% compared to 2022. 63% of Giordano's compensation, or $405K, was in salary. Giordano also received $203K in non-equity incentive plan and $37K in other compensation.
Stuart Rich, Chief Medical Officer, received a compensation package of $481K, which increased by 3% compared to previous year. 66% of the compensation package, or $318K, was in salary.
Eliot M. Lurier, Chief Financial Officer, earned $166K in 2023, a 25% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on September 27, 2024.